Next Article in Journal
Cost-Effectiveness of Molecularly Guided Treatment in Diffuse Large B-Cell Lymphoma (DLBCL) in Patients under 60
Previous Article in Journal
PARP Inhibitors and Radiometabolic Approaches in Metastatic Castration-Resistant Prostate Cancer: What’s Now, What’s New, and What’s Coming?
 
 
Article

Article Versions Notes

Cancers 2022, 14(4), 903; https://doi.org/10.3390/cancers14040903
Action Date Notes Link
article pdf uploaded. 11 February 2022 18:45 CET Version of Record https://www.mdpi.com/2072-6694/14/4/903/pdf-vor
article supplementary file uploaded. 11 February 2022 18:45 CET - https://www.mdpi.com/2072-6694/14/4/903#supplementary
article xml file uploaded 14 February 2022 02:36 CET Original file -
article xml uploaded. 14 February 2022 02:36 CET Update -
article pdf uploaded. 14 February 2022 02:36 CET Updated version of record https://www.mdpi.com/2072-6694/14/4/903/pdf-vor
article html file updated 14 February 2022 02:38 CET Original file -
article xml file uploaded 21 February 2022 10:45 CET Update -
article xml uploaded. 21 February 2022 10:45 CET Update https://www.mdpi.com/2072-6694/14/4/903/xml
article pdf uploaded. 21 February 2022 10:45 CET Updated version of record https://www.mdpi.com/2072-6694/14/4/903/pdf
article html file updated 21 February 2022 10:47 CET Update -
article html file updated 21 February 2022 10:54 CET Update -
article html file updated 31 July 2022 15:44 CEST Update https://www.mdpi.com/2072-6694/14/4/903/html
Back to TopTop